Juan Jesús
Cruz Hernández
Profesor Emérito Honorífico


Centro Nacional de Investigaciones Oncológicas
Madrid, EspañaPublications in collaboration with researchers from Centro Nacional de Investigaciones Oncológicas (4)
2023
2018
-
Phase II pilot study of the prednisone to dexamethasone switch in metastatic castration-resistant prostate cancer (mCRPC) patients with limited progression on abiraterone plus prednisone (SWITCH study)
British Journal of Cancer, Vol. 119, Núm. 9, pp. 1052-1059
2017
-
A novel capillary nano-immunoassay for assessing androgen receptor splice variant 7 in plasma. Correlation with CD133 antigen expression in circulating tumor cells. A pilot study in prostate cancer patients
Clinical and Translational Oncology, Vol. 19, Núm. 11, pp. 1350-1357
2014
-
Role of XRCC3, XRCC1 and XPD single-nucleotide polymorphisms in survival outcomes following adjuvant chemotherapy in early stage breast cancer patients
Clinical and Translational Oncology, Vol. 16, Núm. 2, pp. 158-165